A Trial of Behavioral Economic Interventions to Reduce Cardiovascular Disease (CVD) Risk
A Randomized Trial of Behavioral Economic Interventions to Reduce CVD Risk
Sponsor: Brigham and Women's Hospital
Listed as NCT01346189, this NA trial focuses on Cardiovascular Disease and remains completed. Sponsored by Brigham and Women's Hospital, it has been updated 9 times since 2011, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2022 — Jul 2024 [monthly]
Completed NA
-
Dec 2021 — Jan 2022 [monthly]
Completed NA
-
Jan 2021 — Dec 2021 [monthly]
Completed NA
▶ Show 4 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Dec 2017 — Jun 2018 [monthly]
Completed NA
-
May 2017 — Dec 2017 [monthly]
Completed NA
Phase: PHASE3 → NA
-
Jan 2017 — May 2017 [monthly]
Completed PHASE3
First recorded
Sep 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Brigham and Women's Hospital
- Carnegie Mellon University
- Geisinger Clinic
- Harvard School of Public Health (HSPH)
- Harvard Vanguard Medical Associates
- National Institute on Aging (NIA)
- University of Pennsylvania
For direct contact, visit the study record on ClinicalTrials.gov .